Vol 89, No 10 (2018)
Research paper
Published online: 2018-10-31

open access

Page views 1870
Article views/downloads 1140
Get Citation

Connect on Social Media

Connect on Social Media

The powerful association of angiotensin-converting enzyme insertion/deletion polymorphism and idiopathic recurrent pregnancy loss

Evren Gumus1
Pubmed: 30393847
Ginekol Pol 2018;89(10):573-576.

Abstract

Objectives: Idiopathic recurrent pregnancy loss (IRPL) is one of the most troublesome complications of pregnancy. Several researches were also conducted to search the possible association with ACE I/D polymorphism and IRPL. In the light of these reports, this case-control study was investigated to genotypes and alleles of ACE I/D polymorphism in IRPL group and control group.
Material and methods: Overall, 1176 subjects (1007 cases, 169 controls) were investigated. Allele genotype distributions were determined by PCR method in both groups. Differences in genotype and allele frequencies between groups were investigated by Pearson chi-square tests. The odds ratio (OR) and 95% confidence intervals (95% CI) were also determined.
Results: For the ACE I/D polymorphism I and D allele frequencies were in the control and case groups respectively; 49.4 and 41.6%, 50.6 and 58.4%. The genotypes of ACE for I/D observed in control and case group respectively were as follows; II (27.2 and 17.9), ID (44.4 and 47.4) and DD (28.4 and 34.7). Regarding the distribution of D allele and genotypes containing D allele, we observed significant statistical differences between case and control groups.
Conclusions: Our results showed that the ACE I/D polymorphism was associated with IRPL, and that women that carried DD or ID genotypes had a 72% elevated risk of developing IRPL than women with the II genotype (OR (95% CI): 1.72 (1.181–2.5)). This odds ratio was found to be 1.61 in a case-control study and 1.28 in a meta-analysis study compiling 11 separate studies, which is consistent with our study data.

Article available in PDF format

View PDF Download PDF file

References

  1. Stephenson M, Kutteh W. Evaluation and management of recurrent early pregnancy loss. Clin Obstet Gynecol. 2007; 50(1): 132–145.
  2. Jauniaux E, Farquharson RG, Christiansen OB, et al. Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Hum Reprod. 2006; 21(9): 2216–2222.
  3. Kurzawińska G, Barlik M, Drews K, et al. Coexistence of ACE (I/D) and PAI-1 (4G/5G) gene variants in recurrent miscarriage in Polish population. Ginekol Pol. 2016; 87(4): 271–276.
  4. Larsen EC, Christiansen OB, Kolte AM, et al. New insights into mechanisms behind miscarriage. BMC Med. 2013; 11: 154.
  5. Baek KH, Lee EJ, Kim YS. Recurrent pregnancy loss: the key potential mechanisms. Trends Mol Med. 2007; 13(7): 310–317.
  6. Li J, Chen Y, Wu H, et al. Apolipoprotein E (Apo E) gene polymorphisms and recurrent pregnancy loss: a meta-analysis. J Assist Reprod Genet. 2014; 31(2): 139–148.
  7. Ford HB, Schust DJ. Recurrent pregnancy loss: etiology. Diagnosis and therapy. Rev Obstet Gynecol. 2009; 2(2): 76–83.
  8. Chatzidimitriou M, Chatzidimitriou D, Mavridou M, et al. Thrombophilic gene polymorphisms and recurrent pregnancy loss in Greek women. Int J Lab Hematol. 2017; 39(6): 590–595.
  9. Choi YiS, Kwon H, Kim JiH, et al. Haplotype-based association of ACE I/D, AT1R 1166A>C, and AGT M235T polymorphisms in renin-angiotensin-aldosterone system genes in Korean women with idiopathic recurrent spontaneous abortions. Eur J Obstet Gynecol Reprod Biol. 2011; 158(2): 225–228.
  10. Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990; 86(4): 1343–1346.
  11. Fatini C, Gensini F, Battaglini B, et al. Angiotensin-converting enzyme DD genotype, angiotensin type 1 receptor CC genotype, and hyperhomocysteinemia increase first-trimester fetal-loss susceptibility. Blood Coagul Fibrinolysis. 2000; 11(7): 657–662.
  12. Bukreeva L, Grigorov A, Kiesewetter H, et al. Association of angiotensin-converting enzyme intron 16 insertion/deletion polymorphism with history of foetal loss. J Renin Angiotensin Aldosterone Syst. 2009; 10(4): 237–240.
  13. Al-Mukaynizi FB, AlKhuriji A, Babay Z, et al. Lack of Association between Angiotensin Converting Enzyme I/D Polymorphism and Unexplained Recurrent Miscarriage in Saudi Arabia. J Med Biochem. 2016; 35(2): 166–173.
  14. Heidari MM, Sheikholeslami M, Yavari M, et al. The association of renin-angiotensinogen system genes polymorphisms and idiopathic recurrent pregnancy loss. Hum Fertil (Camb). 2017 [Epub ahead of print]: 1–7.
  15. Fazelnia S, Farazmandfar T, Hashemi-Soteh SM. Significant correlation of angiotensin converting enzyme and glycoprotein IIIa genes polymorphisms with unexplained recurrent pregnancy loss in north of Iran. Int J Reprod Biomed (Yazd). 2016; 14(5): 323–328.
  16. Kim JJu, Choi YM, Lee SKi, et al. The PAI-1 4G/5G and ACE I/D polymorphisms and risk of recurrent pregnancy loss: a case-control study. Am J Reprod Immunol. 2014; 72(6): 571–576.
  17. Zhao J, Qin X, Li S, et al. Association between the ACE I/D polymorphism and risk of ischemic stroke: an updated meta-analysis of 47,026 subjects from 105 case-control studies. J Neurol Sci. 2014; 345(1-2): 37–47.
  18. Rahimi Z. ACE insertion/deletion (I/D) polymorphism and diabetic nephropathy. J Nephropathol. 2012; 1(3): 143–151.
  19. Shakarami F, Akbari MT, Zare Karizi S. Association of plasminogen activator inhibitor-1 and angiotensin converting enzyme polymorphisms with recurrent pregnancy loss in Iranian women. Iran J Reprod Med. 2015; 13(10): 627–632.
  20. Dossenbach-Glaninger A, van Trotsenburg M, Schneider B, et al. ACE I/D polymorphism and recurrent first trimester pregnancy loss: interaction with SERPINE1 4G/5G and F13 Val34Leu polymorphisms. Br J Haematol. 2008; 141(2): 269–271.
  21. López-Jiménez JJ, Porras-Dorantes Á, Juárez-Vázquez CI, et al. Molecular thrombophilic profile in Mexican patients with idiopathic recurrent pregnancy loss. Genet Mol Res. 2016; 15(4).
  22. Sun L, Lv H, Wei W, et al. Angiotensin-converting enzyme D/I and plasminogen activator inhibitor-1 4G/5G gene polymorphisms are associated with increased risk of spontaneous abortions in polycystic ovarian syndrome. J Endocrinol Invest. 2010; 33(2): 77–82.
  23. Ivanov P, Konova E, Komsa-Penkova R, et al. [Preplacentation pregnancy loss in cases of angiotensin-converting enzyme insertion/deletion polymorphism]. Akush Ginekol (Sofiia). 2014; 53(4): 12–16.
  24. Vettriselvi V, Vijayalakshmi K, Paul SFD, et al. ACE and MTHFR gene polymorphisms in unexplained recurrent pregnancy loss. J Obstet Gynaecol Res. 2008; 34(3): 301–306.
  25. Su MT, Lin SH, Chen YC, et al. Genetic association studies of ACE and PAI-1 genes in women with recurrent pregnancy loss. Thrombosis and Haemostasis. 2012; 109(1): 8–15.
  26. Ozdemir O, Yenicesu GI, Silan F, et al. Recurrent pregnancy loss and its relation to combined parental thrombophilic gene mutations. Genet Test Mol Biomarkers. 2012; 16(4): 279–286.